Physician profile
Brittney A Misercola
NPI 1104178037
$223,433.73
in general payments reported to CMS, 2019-2025
18 companies · $828 in 2025
The $828 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23K · 2022: $83K · 2023: $65K · 2024: $51K · 2025: $828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $69K · Travel and Lodging: $18K · Food and Beverage: $18K · Consulting Fee: $8,840 · Education: $2,554 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $69,126.19 |
| Travel and Lodging | $18,409.23 |
| Food and Beverage | $17,780.41 |
| Consulting Fee | $8,840.04 |
| Education | $2,554.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $78,936.75 | 2021-2025 | Proclaim, Infinity, Eterna |
| Relievant Medsystems, INC. | $58,880.85 | 2021-2023 | Intracept |
| Boston Scientific Corporation | $36,149.31 | 2021-2024 | Intracept |
| Painteq LLC | $24,467.33 | 2021-2024 | Painteq |
| Spinal Simplicity, LLC | $19,994.66 | 2021-2024 | Ha Minuteman G3-R |
| Medtronic, INC. | $1,754.77 | 2022-2024 | Synchromedii, Intellis Adaptivestim |
| Nevro Corp. | $905.10 | 2022-2024 | Senza |
| Spr Therapeutics, INC | $705.04 | 2021-2023 | Sprint Pns System |
| Nalu Medical, INC. | $409.56 | 2021-2024 | Nalu Neurostimulation System |
| Biotronik Nro, INC. | $305.18 | 2023-2024 | Biotronik, Prospera |
| Vertos Medical, INC. | $263.37 | 2023-2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $190.75 | 2025 | Evoke |
| Curonix LLC | $122.59 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Grt US Holding, INC. | $118.21 | 2021-2022 | |
| Bioventus LLC | $113.67 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $83.20 | 2025 | |
| Averitas Pharma INC. | $21.57 | 2023 | Qutenza |
| Arbor Pharmaceuticals, INC. | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittney Misercola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.